Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor

Brain Research

Volumn 852, Issue 1, 2000, Pages 198-207

  Xu, Ming ^a   Guo, Yihe ^a   Vorhees, Charles V ^b   Zhang, Jianhua ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Amphetamine; Cocaine; D1 receptor; Knockout mice

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE 1 RECEPTOR; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D1; REFERENCE VALUES;

EID: 0033985297     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02258-1     Document Type: Article

References (45)

1. Broening H.W., Pu C., Vorhees C.V. Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse. 27:1997;153-160.
2. 2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology. 105:1991;335-339.
3. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 33:1993;281-307.
4. Crawford C.A., Drago J., Watson J.B., Levine M.S. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. NeuroReport. 8:1997;2523-2527.
5. Delfs J.M., Schreiber L., Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci. 10:1990;303-310.
6. A dopamine receptors. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12564-12568.
7. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
8. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:1993;299-321.
9. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6912-6916.
10. Henry D.J., White F.J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:1991;882-890.
11. Hiroi N., White N.M. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552:1991;141-152.
12. Hyman S.E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
13. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1998;1979-1986.
14. Kalivas P.W., Duffy P. The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 5:1990;48-58.
15. Kalivas P.W., Stewart J. Dopamine neurotransmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
16. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine: I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
17. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
18. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
19. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
20. Koob G.F. Drug addiction: the Yin and Yang of hedonic homeostasis. Neuron. 16:1996;893-896.
21. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278:1997;52-57.
22. Kuczenski R., Segal D.S. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9:1989;2051-2065.
23. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
24. Kuribara H. Dopamine D1 receptor antagonist SCH23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice. Pharmacol. Biochem. Behav. 52:1995;759-763.
25. Laviola G., Dell'Omo G., Chiarotti F., Bignami G. D-Amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. Behav. Neurosci. 3:1994;514-524.
26. Mattingly B.A., Hart T.C., Lim K., Perkins C. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology. 114:1994;239-242.
27. Mattingly B.A., Rowlett J.K., Ellison T., Rase K. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH23390 treatments. Pharmacol. Biochem. Behav. 53:1996;481-486.
28. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
29. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
30. Roberts D.C.S., Corcoran M.E., Fibiger H.C. On the role of ascending catecholamine systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:1977;615-620.
31. Roberts D.C.S., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:1980;781-787.
32. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
33. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
34. D.S. Segal, R. Kuczenski, Behavioral pharmacology of amphetamine, in: A.K. Cho, D.S. Segal (Eds.), Amphetamine and its Analogs, Academic Press, San Diego, 1994, pp. 115-150.
35. Segal D.S., Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci. 17:1997;2552-2566.
36. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
37. Sibley D.R., Monsma F.J. Jr., Shen Y. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35:1993;391-415.
38. Steketee J.D. Injection of SCH23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine. Behav. Pharmacol. 9:1998;69-76.
39. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promoters reverse transport. J. Neurosci. 15:1995;4102-4108.
40. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16:1996;2411-2420.
41. E.R. Weibel, Stereological Methods. Practical Methods for Biological Morphometry, Vol. 1., Academic Press, London, 1979.
42. White F.J., Joshi A., Koeltzow T.E., Hu X.T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychophamacology. 18:1998;26-40.
43. B.J. Winer, D.R. Brown, K.M. Michels, Statistical Principles in Experimental Design, 3rd edn., McGraw-Hill, New York, 1991.
44. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
45. Xu M., Hu X-T., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79:1994;945-955.